| Metric | Q3 2020 | Q2 2020 | Q3 2019 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $10.9B | $9.4B | $12.4B | 16.9% | -11.8% |
| Op. Income | $2.5B | $2.4B | $2.6B | 2.9% | -4.1% |
| Gross Margin | 72.4% | 70.6% | 67.8% | 1.8pp | 4.6pp |
| Net Margin | 26.9% | 32.1% | 15.3% | -5.2pp | 11.6pp |
| EPS (Diluted) | $1.16 | $1.18 | $0.74 | -1.7% | 56.8% |
| Free Cash Flow | $728M | $2.8B | $3.3B | -74.0% | -77.7% |
| Item | Amount |
|---|---|
| REVENUE | $10.9B |
| Cost of Revenue | $3.0B |
| GROSS PROFIT | $7.9B |
| R&D Expenses | $3.3B |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $2.1B |
| Other Expenses | $0 |
| Operating Expenses | $5.4B |
| Cost & Expenses | $8.4B |
| OPERATING INCOME | $2.5B |
| Interest Income | $9M |
| Interest Expense | $203M |
| Other Income/Expenses | $199M |
| INCOME BEFORE TAX | $2.7B |
| Income Tax Expense | $380M |
| Net Income from Continuing Ops | $2.3B |
| Net Income from Discontinued Ops | $617M |
| Other Adjustments | -$617M |
| NET INCOME | $2.9B |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $2.9B |
| D&A | $807M |
| EBIT | $2.9B |
| EBITDA | $3.7B |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $10.9B |
| Cost of Revenue | $3.0B |
| GROSS PROFIT | $7.9B |
| R&D Expenses | $3.3B |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $2.1B |
| Other Expenses | $0 |
| Operating Expenses | $5.4B |
| Cost & Expenses | $8.4B |
| OPERATING INCOME | $2.5B |
| Interest Income | $9M |
| Interest Expense | $203M |
| Other Income/Expenses | $199M |
| INCOME BEFORE TAX | $2.7B |
| Income Tax Expense | $380M |
| Net Income from Continuing Ops | $2.3B |
| Net Income from Discontinued Ops | $617M |
| Other Adjustments | -$617M |
| NET INCOME | $2.9B |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $2.9B |
| D&A | $807M |
| EBIT | $2.9B |
| EBITDA | $3.7B |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $2.9B |
| Depreciation & Amortization | $852M |
| Stock-Based Compensation | $116M |
| Deferred Income Tax | -$75M |
| Other Non-Cash Items | -$228M |
| Change in Working Capital | -$1.4B |
| OPERATING CASH FLOW | $2.2B |
| Capital Expenditure | -$1.4B |
| Acquisitions (Net) | -$586M |
| Purchases of Investments | -$1M |
| Sales/Maturities of Investments | $2M |
| Other Investing Activities | -$54M |
| NET CASH FROM INVESTING | -$2.2B |
| Net Debt Issuance | -$2.3B |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | -$1.5B |
| Other Financing Activities | -$28M |
| NET CASH FROM FINANCING | -$3.9B |
| FREE CASH FLOW | $728M |
| Net Change in Cash | -$3.7B |
| Item | Amount |
|---|---|
| Cash & Equivalents | $7.4B |
| Short-Term Investments | $0 |
| Net Receivables | $8.4B |
| Inventory | $8.2B |
| Other Current Assets | $2.6B |
| TOTAL CURRENT ASSETS | $26.6B |
| PP&E (Net) | $16.9B |
| Goodwill | $20.2B |
| Intangible Assets | $16.7B |
| Long-Term Investments | $1.4B |
| Tax Assets | $0 |
| Other Non-Current Assets | $8.0B |
| TOTAL NON-CURRENT ASSETS | $63.2B |
| TOTAL ASSETS | $89.8B |
| Account Payables | $3.7B |
| Short-Term Debt | $2.4B |
| Deferred Revenue | $0 |
| Other Current Liabilities | $0 |
| TOTAL CURRENT LIABILITIES | $20.4B |
| Long-Term Debt | $26.3B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $1.8B |
| Other Non-Current Liabilities | $12.0B |
| TOTAL NON-CURRENT LIABILITIES | $40.1B |
| TOTAL LIABILITIES | $60.5B |
| Common Stock | $1.8B |
| Additional Paid-In Capital | $39.5B |
| Retained Earnings | $51.1B |
| Treasury Stock | -$56.8B |
| Accum. Other Comp. Income | -$6.4B |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $29.2B |
| Minority Interest | $84M |
| TOTAL EQUITY | $29.3B |
| TOTAL LIABILITIES & EQUITY | $89.8B |
| Total Debt | $28.7B |
| Net Debt | $21.4B |
